Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Role of T lymphocytes in the pathogenesis of Chlamydia disease.

Igietseme JU, He Q, Joseph K, Eko FO, Lyn D, Ananaba G, Campbell A, Bandea C, Black CM.

J Infect Dis. 2009 Sep 15;200(6):926-34. doi: 10.1086/605411.

4.
5.
6.
9.
10.
11.

Murine Chlamydia trachomatis genital infection is unaltered by depletion of CD4+ T cells and diminished adaptive immunity.

Morrison SG, Farris CM, Sturdevant GL, Whitmire WM, Morrison RP.

J Infect Dis. 2011 Apr 15;203(8):1120-8. doi: 10.1093/infdis/jiq176.

12.

Outer membrane proteins preferentially load MHC class II peptides: implications for a Chlamydia trachomatis T cell vaccine.

Karunakaran KP, Yu H, Jiang X, Chan Q, Moon KM, Foster LJ, Brunham RC.

Vaccine. 2015 Apr 27;33(18):2159-66. doi: 10.1016/j.vaccine.2015.02.055.

14.

Chlamydia muridarum T cell antigens and adjuvants that induce protective immunity in mice.

Yu H, Karunakaran KP, Jiang X, Shen C, Andersen P, Brunham RC.

Infect Immun. 2012 Apr;80(4):1510-8. doi: 10.1128/IAI.06338-11.

15.

Innate immunity is sufficient for the clearance of Chlamydia trachomatis from the female mouse genital tract.

Sturdevant GL, Caldwell HD.

Pathog Dis. 2014 Oct;72(1):70-3. doi: 10.1111/2049-632X.12164.

16.

Antigen-specific CD4+ T cells produce sufficient IFN-gamma to mediate robust protective immunity against genital Chlamydia muridarum infection.

Li W, Murthy AK, Guentzel MN, Seshu J, Forsthuber TG, Zhong G, Arulanandam BP.

J Immunol. 2008 Mar 1;180(5):3375-82.

17.

PD-L1 limits the mucosal CD8+ T cell response to Chlamydia trachomatis.

Fankhauser SC, Starnbach MN.

J Immunol. 2014 Feb 1;192(3):1079-90. doi: 10.4049/jimmunol.1301657.

18.

Fc receptor regulation of protective immunity against Chlamydia trachomatis.

Moore T, Ananaba GA, Bolier J, Bowers S, Belay T, Eko FO, Igietseme JU.

Immunology. 2002 Feb;105(2):213-21.

19.

Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae.

Su H, Messer R, Whitmire W, Fischer E, Portis JC, Caldwell HD.

J Exp Med. 1998 Sep 7;188(5):809-18.

20.

Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.

Ifere GO, He Q, Igietseme JU, Ananaba GA, Lyn D, Lubitz W, Kellar KL, Black CM, Eko FO.

J Microbiol Immunol Infect. 2007 Jun;40(3):188-200.

PMID:
17639158

Supplemental Content

Support Center